UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Will Biogen win FDA nod for Alzheimer’s drug aducanumab?
by Kim Yun-mi
2020-07-09 16:06
Regulator to reclassify dermatological cream Lidomex as prescription drug
by Kim Yun-mi
2020-07-08 11:24
‘Study results on MSD’s Keytruda very disappointing’
by Kim Yun-mi
2020-07-07 16:43
Experts showed mixed preferences between 2 diabetes treatments
by Kim Yun-mi
2020-07-06 14:20
MSD Korea reshuffles personnel before spinoff of Organon
by Kim Yun-mi
2020-07-02 13:44
라인
[Special] HIV patients pushed aside amid Covid-19 crisis
by Kim Yun-mi
2020-07-01 16:18
Hanmi, Novartis in patent dispute over diabetes drug
by Kim Yun-mi
2020-06-25 13:59
Labor-management dispute runs deep at MSD Korea
by Kim Yun-mi
2020-06-23 12:06
RIGHT Fund adds ₩18 billion to support for infectious disease research
by Kim Yun-mi
2020-06-22 17:22
‘Pfizer’s Vyndaqel, Vyndamax do not deserve rare disease pricing’
by Kim Yun-mi
2020-06-22 17:19
라인
New diabetes drug Steglatro fails to prove cardiovascular benefit
by Kim Yun-mi
2020-06-19 14:55
AZ’s Imfinzi wins extra indication for small-cell lung cancer
by Kim Yun-mi
2020-06-18 15:55
Lilly beats Pfizer in treating early breast cancer
by Kim Yun-mi
2020-06-18 14:44
‘Tecentriq, major turning point for triple-negative breast cancer treatment’
by Kim Yun-mi
2020-06-18 14:43
IOF aims to reduce osteoporosis-related fractures by 25% by 2025
by Kim Yun-mi
2020-06-17 14:28
라인
Regulator to discuss re-evaluation of choline alfoscerate
by Kim Yun-mi
2020-06-17 12:36
‘Celltrion has no reason to save Takeda Korea workers’ jobs’
by Kim Yun-mi
2020-06-16 11:44
Jardiance family of diabetes drugs sells ₩10 billion in Q1
by Kim Yun-mi
2020-06-15 17:39
Biogen’s FDA application for Alzheimer’s drug drags on
by Kim Yun-mi
2020-06-15 12:09
Immunotherapies potent on rare small-cell lung cancer, biliary tract cancer
by Kim Yun-mi
2020-06-12 12:03
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top